Delayed drug hypersensitivity reactions.

Area of Science:

• Immunology
• Dermatology
• Pharmacology

Background:

• Immune reactions to small molecules, including drugs, can lead to diverse diseases affecting organs like skin, liver, kidneys, and lungs.
• Drug hypersensitivity reactions often involve drug-specific CD4+ and CD8+ T cells recognizing drugs via T-cell receptors in a MHC-dependent manner.

Purpose of the Study:

• To investigate the role of distinct T cell functions in mediating different clinical phenotypes of drug-induced exanthema.
• To explore the subclassification of delayed hypersensitivity reactions (Type IV) based on T cell effector functions.

Main Methods:

• Immunohistochemical and functional studies of drug-reactive T cells in patients with various forms of exanthema.
• Analysis of T cell-mediated cytokine and chemokine release, and cytotoxic functions.

Main Results:

• Distinct T cell functions correlate with specific clinical presentations; for example, CD4+ T cells killing keratinocytes in maculopapular exanthema, and CD8+ T cells associated with blistering.
• Drug-specific T cells release cytokines (e.g., IL-5, IFN) and chemokines (e.g., IL-8) that orchestrate inflammatory responses.
• Data support subclassification of Type IV hypersensitivity into subsets based on recruited cells (monocytes - IVa, eosinophils - IVb, neutrophils - IVd) and cytotoxic T cell activity (IVc).

Conclusions:

• T cell recognition of drugs, either directly or as haptens, drives hypersensitivity.
• Specific T cell effector mechanisms determine the clinical phenotype of drug reactions, enabling a more refined classification of delayed hypersensitivity.
• Cytotoxic T cell functions (CD4+ or CD8+) appear to be a common feature across all Type IV reactions.